🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

17 results for “Cellectar Biosciences” Clear

  1. Paclitaxel

    Cellectar Biosciences

    Non Small Cell Lung Cancer

    phase 3 small molecule completed

    1 trial

  2. I-124-CLR1404

    Cellectar Biosciences

    Glioblastoma

    phase 2 small molecule terminated

    1 trial

  3. I-131-CLR1404 Injection

    Cellectar Biosciences

    Glioma

    phase 2 small molecule terminated

    1 trial

  4. Iopofosine I 131 single dose

    Cellectar Biosciences

    Waldenstrom Macroglobulinemia

    phase 2 small molecule active

    1 trial

  5. NOV-002

    Cellectar Biosciences

    Ovarian Cancer

    phase 2 small molecule completed

    1 trial

  6. NOV-002

    Cellectar Biosciences

    Leukemia

    phase 2 small molecule terminated

    1 trial

  7. NOV-205

    Cellectar Biosciences

    Hepatitis C

    phase 2 small molecule completed

    2 trials

  8. POTASSIUM IODIDE

    Cellectar Biosciences

    Waldenstrom Macroglobulinemia

    phase 2 small molecule active

    1 trial

  9. CLR 131

    Cellectar Biosciences

    Head and Neck Cancer

    phase 1 small molecule completed

    1 trial

  10. CLR 131

    Cellectar Biosciences

    High-Grade Glioma

    phase 1 small molecule active

    1 trial

  11. CLR 131

    Cellectar Biosciences

    Pediatric Solid Tumor

    phase 1 small molecule active

    1 trial

  12. I-131-CLR1404

    Cellectar Biosciences

    Solid Tumors

    phase 1 small molecule completed

    1 trial

  13. I-131-CLR1404

    Cellectar Biosciences

    Multiple Myeloma

    phase 1 small molecule completed

    1 trial

  14. I-131-CLR1404

    Cellectar Biosciences

    Cancer

    phase 1 small molecule completed

    1 trial

  15. I124-NM404

    Cellectar Biosciences

    Non Small Cell Lung Cancer

    phase 1 small molecule completed

    1 trial

  16. Iopofosine I 131

    Cellectar Biosciences

    Breast Cancer

    phase 1 small molecule active

    1 trial

  17. RNL-Vascostem®

    Cellectar Biosciences

    Buerger's Disease

    mab completed

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources